Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?
Crossref DOI link: https://doi.org/10.1186/s12977-018-0433-2
Published Online: 2018-07-28
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Subbaraman, Harini
Schanz, Merle
Trkola, Alexandra http://orcid.org/0000-0003-1013-876X
Funding for this research was provided by:
Swiss National Science Foundation (SNF #314730_172790)
Text and Data Mining valid from 2018-07-28
Article History
Received: 18 May 2018
Accepted: 21 July 2018
First Online: 28 July 2018